In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol. 2022 Oct;23(10):1495-1506. doi: 10.1038/s41590-022-01315-x. Epub 2022 Sep 23.
Nat Immunol. 2022.
PMID: 36151395